Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Louisiana Obese Subjects Study (LOSS)
NCT00115063Phase 4Terminated
- Sponsor
- Pennington Biomedical Research Center
- Start
- Jul 2005
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sibutramine, orlistat, amfepramone in obesity, sponsored by Pennington Biomedical Research Center. Started Jul 2005; status: terminated.
02
Drugs
sibutramineorlistatamfepramone
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00115063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115063.